Morning-Outlook-Feature-Image

morning-outlook-27june1

Nifty opened on a flat note and as the day progressed it gained momentum and closed with gains of 175.5 points. On the daily charts Nifty has witnessed a vertical rally in the last four trading sessions.

Today the IT Index was one of the major contributors which helped Nifty to close above 24000. On upside immediate hurdle is placed at 24150 – 24300 while support on lower side would be 23950-23850.

The market breadth has been deteriorating since the last three trading sessions hence caution is advised as we have updated during the day.

BSE Sensex and Nfity50 indices hit new record highs of 79,396.03 and 24,087.45, respectively.  The Nifty Bank index also hit a fresh record high of 53,180.75.

Once again Mid and Small caps underperformed the Frontline Index.

TECHNICAL PICKS

COMPANY NAME PRICE RANGE B/S SL TARGET
SBI 838-842 BUY 830 860
HDFC LIFE 590-592 BUY 583 607

DERIVATIVE PICKS

Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
ULTRACEMCO.24.06 Jun 11710 5.38 30.92 602500 GODREJCP.24.06 Jun 1368.2 -3.05 44.39 1364500
LTIM.24.06 Jun 5358.15 3.62 1.42 899400 BANDHANBNK.24.06 Jun 200 -2.72 0.11 25585000
ABB.24.06 Jun 8696.55 3.6 1.98 334125 POLYCAB.24.06 Jun 7009 -2.53 24.04 270900
CUMMINSIND.24.06 Jun 4127.3 3.04 8.96 569400 LT.24.06 Jun 3554.2 -1.28 25.83 3757350
DRREDDY.24.06 Jun 6241.5 2.93 15.8 647625 PIDILITIND.24.06 Jun 3144.7 -1.16 34.08 551750
                                                                        Short Covering                                                                       Long Unwinding
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
INDIACEM.24.06 Jun 292.5 11.13 -10.8 4190500 CHAMBLFERT.24.06 Jun 495.85 -4.68 -4.37 2787300
MANAPPURAM.24.06 Jun 210.2 6.97 -11.42 6702000 PNB.24.06 Jun 119.05 -4.53 -23.73 1.43E+08
BOSCHLTD.24.06 Jun 35800 5 -21.97 34450 AUBANK.24.06 Jun 664.2 -4.3 -37.61 4532000
OFSS.24.06 Jun 9869.95 3.91 -23.63 182600 GNFC.24.06 Jun 667.65 -3.5 -5.56 3931200
IDEA.24.06 Jun 18.65 3.32 -25.2 391120000 HAVELLS.24.06 Jun 1852.8 -3.34 -33.96 1136500

 

TOP DELIVERY PERCENTAGE

Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Value (Lakh)
Sun Pharma  Ltd 1516.25 -0.32 3881458 1930824 75.32 Nifty50 24044.5 0.74 17138.52
Marico Limited 611.65 -0.24 2676129 2035797 75.06 Nifty bank 52811.3 -0.11 37755.15
Larsen & Toubro Limited 3564.4 -1.07 5519875 1820682 73.41 Nifty it 36123.7 2.03 25631.27
Mah & Mah Ltd. 2888.95 1.31 6900180 2399459 73.1 India Vix 13.92 -0.85 11.51
Infosys Limited 1573.35 2.12 14757754 3506433 72.28 Nifty Fmcg 56670.6 0.36 40418.76
Voltas Ltd. 1503.05 0.51 1004585 1133020 71.72 Nifty Pharma 19514.8 -0.16 13941.19
Titan Company Limited 3380.6 0.23 1462935 1051250 70.76 Nifty Realty 1098.95 -0.05 784.63
Aurobindo Pharma Ltd. 1190.25 -0.64 4916440 1373890 70.2 Nifty Auto 25191.4 0.69 17940.67
Indian Hotels Co. Ltd. 624.4 -3.93 6641760 3043107 69.13 Nifty Metal 9767.4 0.55 6963.08
Tata Consultancy Serv Lt 3934.15 2.03 4526556 1131357 68.99 Nifty Media 1996.2 -1.35 1432.89

UPCOMING ECONOMIC DATA

   Domestic                                                                                                                                                  International 
INR: Bank loan and Deposit growth on 28th June

INR :  manufacturing PMI on 1st July 24

INR :  Parliament Session (24th June, 2024 to 3rd July, 2024).

GBP: Q1 GDP of Britain on 28th June,  Fed Monetary Policy Report on 28th June

USD: ISM Mfg PMI on 1st July

USD: Fed Chair Powell speaks on 2nd July

 

NEWS UPDATES

  • Indian scheduled commercial banks (SCBs) continue to report robust credit growth and asset quality of the banks also continue to improve- RBI Financial Stability Report (FSR).

 

  • PI Industries subsidiary will acquire Plant Health Care Plc, a UK-incorporated agriculture biological inputs company, for £32.78 million.
    Ambuja Cements Board approves merger of Adani Cementation with the company

 

  • According to the report, the Robert Bosch has been discussing the possibility of making an offer for Whirlpool, which has a market capitalisation of around $4.8 billion.

 

  • Emcure Pharmaceuticals Ltd.’s initial public offering to raise Rs 800 crore from the primary market will open on July 3 and conclude on July 5.

 

Source: Moneycontrol, Economic Times,  Indian Express, Business Today, Livemint, Business Standard

BOARD MEETINGS

Company Name Purpose Meeting Date Company Name Purpose Meeting Date
ALEXANDER A.G.M. 28-Jun-24 AHLWEST Audited Results 29-Jun-24
CENLUB General 28-Jun-24 ASTALLTD Issue Of Warrants;A.G.M. 29-Jun-24
GOCOLORS General 28-Jun-24 MAHASTEEL General 29-Jun-24
KACL General 28-Jun-24 MITSHI Audited Results;General 29-Jun-24
KIMIABL General 28-Jun-24 STDSHOE General 29-Jun-24
KIMS Stock  Split;General 28-Jun-24 SURYALA General 29-Jun-24
KRONOX Audited Results 28-Jun-24 BSELALGO Preferential Issue of shares;General 30-Jun-24
LCCINFOTEC General 28-Jun-24 SBVCL General 30-Jun-24
LIKHAMI A.G.M.;General 28-Jun-24 VINTRON Audited Results 30-Jun-24
PANJON Preferential Issue of shares;General 28-Jun-24 BERYLSE A.G.M. 01-Jul-24
RAJOOENG Final Dividend;Bonus issue 28-Jun-24 DMR Right Issue of Equity Shares 01-Jul-24
RATNAVEER Increase in Authorised Capital;Preferential Issue 28-Jun-24 SAKUMA Bonus issue;General 01-Jul-24
RRETAIL General 28-Jun-24 SPRAYKING Bonus issue;General 01-Jul-24
SINNAR Voluntary Delisting of Shares 28-Jun-24 UNICK General 01-Jul-24
UPSURGE General 28-Jun-24 SUNDARAM General 02-Jul-24
VEDAVAAG Preferential Issue of shares 28-Jun-24 ECOBOAR A.G.M.;General  

06-Jul-24

CORPORATE ACTION

Company Name Ex-Date Purpose Company Name Ex-Date Purpose
AEROFLEX 28-Jun-24 Final Dividend – Rs. – 0.25 SWARAJENG 28-Jun-24 Final Dividend – Rs. – 95.00
ANDHRAPET 28-Jun-24 Dividend – Rs. – 2.00 SYNGENE 28-Jun-24 Final Dividend – Rs. – 1.25
AVONMORE 28-Jun-24 Split Rs.10/- to Rs.1/- VAIBHAVGBL 28-Jun-24 Final Dividend – Rs. – 1.50
BAJAJHLDNG 28-Jun-24 Final Dividend – Rs. – 21.00 WELCORP 28-Jun-24 Final Dividend – Rs. – 5.00
BANKBARODA 28-Jun-24 Dividend – Rs. – 7.60 GEOJITFSL 01-Jul-24 Final Dividend – Rs. – 1.50
DBOL 28-Jun-24 Final Dividend – Rs. – 2.50 GHCL 01-Jul-24 Final Dividend – Rs. – 12.00
GICHSGFIN 28-Jun-24 Final Dividend – Rs. – 4.50 GHCLTEXTIL 01-Jul-24 Final Dividend – Rs. – 0.50
GPIL 28-Jun-24 Buy Back of Shares LLOYDSENT 01-Jul-24 Final Dividend – Rs. – 0.1000
INDUSINDBK 28-Jun-24 Final Dividend – Rs. – 16.50 TATACOMM 01-Jul-24 Final Dividend – Rs. – 16.7000
KPIL 28-Jun-24 Final Dividend – Rs. – 8.00 BAJAJCON 02-Jul-24 Buy Back of Shares
KSOLVES 28-Jun-24 Interim Dividend – Rs. – 8.00 EPIGRAL 02-Jul-24 Final Dividend – Rs. – 5.00
MAHSCOOTER 28-Jun-24 Final Dividend – Rs. – 60.00 QUESTCAP 02-Jul-24 Final Dividend – Rs. – 2.50
MAWANASUG 28-Jun-24 Final Dividend – Rs. – 4.00 SWASTIKA 02-Jul-24 Final Dividend – Rs. – 2.00
NAM-INDIA 28-Jun-24 Final Dividend – Rs. – 11.00 DALMIASUG 03-Jul-24 Final Dividend – Rs. – 1.25
RECLTD 28-Jun-24 Final Dividend – Rs. – 5.00 GPTINFRA 03-Jul-24 Bonus issue 1:1
RPGLIFE 28-Jun-24 Final Dividend – Rs. – 16.00 JYOTHYLAB 03-Jul-24 Final Dividend – Rs. – 3.50

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

  1. Reports
  2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

  1. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.